Meningoencephalomyelitis Flashcards

1
Q

Define EME

A

eosinophilic meningoencephalitis (EME) is a disorder of unknown etiology that is characterised by infiltration of eosinophilis. It can be a component of fungal/protozoal/parasitic mening, but can be idiopathic as well.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

typical CSF findings in EME

A

eosinophilic pleocytosis (>20%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pathophysiology of EME

A

an autoimmune etiology is suspected. A type I and/or type IV hypersensitivity reaction may be involved with eosinophils releasing neurotoxic substances

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Common MRI findings with idiopathic eosinophilic mening in dogs

A
  • focal or multifocal intra-axial lesions are observed primarily within cortical grey matter and meninges +/- white matter lesions
  • contrast enhanced meninges ( cortical atrophy or necrosis)
  • cerebral sulci enlargement
  • lesions are typically hyperintense on T2-weight images; hypo- to hyperintense on fluid-attenuated inversion recovery (FLAIR) images; hypo- to isointense on T1-weighted images; and may or may not contrast enhance
  • can also be normal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

list potential infectious etiologies of EME in dogs

A
  • canine distemper virus
  • rabies
  • neosporosis
  • toxoplasmosis
  • cryptococcosis
  • protothecosis
  • neural angiostrongylosis
  • intracranial cuterebriasis
  • dirofilarial larval migration
  • bacterial infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

typical signalment for eme

A
  • large-breed dogs; goldens and rottweilers
  • 4 months to 10 years
  • males predisposed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

MOA of corticosteroids in EME

A
  • immunosuppressive therapy; glucocorticoids enter the cell nucleus to interfere with transcription of products important to immune and inflammatory processes
  • neuroprotective effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Prognosis of dogs with idiopathic EME

A
  • good with treatment; 75% respond well to therapy
  • relapses possible
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is pug dog encephalitis?

A

necrotizing encephalitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What distinguishes NME and NLE?

A

lesion distribution;
- NME primarily affects cerebral gray matter
- NLE within subcortical + brainstem white matter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is NE?

A

necrotizing encephalitis; an aseptic inflammatory, necrotizing disease of the brain. Only reported in dogs.
- two discrete forms (1) necrotising meningoencephalitis (NME) + (2) necrotizing leukoencephalitis (NLE)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

etiology of Necrotizing meningitis

A
  • thought to be an autoimmune disease targeting cellular components that are normally shielded
  • no infectious organisms isolated
  • pathogenesis likely multifactorial with genetic predisposition and aberrant immune system stimulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

why is NME also known as pug dog mening?

A
  • strong familial inheritance of NME has been documented in the pug; associated with risk loci on chromosome 15 and the dog leukocyte antigen (DLA) II region of chromosome 12
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pathophysiology of NME

A
  • thought to be a T-cell mediated autoimmune disease
  • altered display of self-antigens to the immune system –> presentation of CNS self antigen to T-cells or cross-reaction of antibodies against a self-protein antigen.
  • activated T-cells cause a cascade of changes; loss of blood-brain barrier integrity, cytokine activation and other inflammatory changes leading to oxidative stress, neurotoxicity, apoptosis, astrogliosis, microglial activation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

typical CSF findings in NME

A
  • mononuclear or lymphocytic pleocytosis (most commonly)
    +/- increased protein concentration (disruption of blood/brain barrier) or intrathecal IgG production
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

is genetic testing available for NME?

A
  • testing for the DLA gene markers on chromosome 12 is commercially available in the USA and UK
  • homozygous affected dogs have an observed risk of 12.75 for NME compared to normal or heterozygous (0-1.08)
17
Q

typical NME signalment

A
  • young adult, small breed dogs
  • pug (fawn, females), yorkshire terrier, maltese, chis, pekingese, papillon, shih tzu, coton de tulear, brussels griffon –> NME
  • french bulldog + yorkshire terrier –> NLE
18
Q

common NLE CS

A

central blindness, seizures, central vestibular signs

19
Q

common NME CS

A
  • forebrain signs; seizures, central blindness, circling, head pressing, altered mentation, head +/- cervical pain
20
Q

MOA of cyclosporine in NME

A
  • kinase/phosphorylase inhibitors
  • calcineurin inhibition stops translocation of nuclear factor of activated T-cells (NFAT) into the nucleus = inhibition of IL-2 + proinflammatory cytokines transcription
  • only modified formulations of cyclosporine (Atopica, Neoral) are well absorbed (administer 1-2hrs before a meal)
21
Q

MOA of DNA Alkylators

A
  • alter DNA conformation by insertion of alkyl group which interferes with DNA repair and replication, as well as inhibiting transcription. They are cell cycle nonspecific.
  • Procarbazine, Lomustine, Cyclophosphamide penetrate into the CNS well
22
Q

examples of antimetabolites

A
  • those affecting purine synthesis; mycophenolate and azathioprine
  • those affect pyrimidine synthesis; cytosine arabinoside, leflunomide
23
Q

MOA of azathioprine

A

interferes with pathways for synthesis of purines; greatest effect on humoral immunity. Requires 8-12 weeks to achieve maximal immunosuppressive effects.

24
Q

MOA of leflunomide

A
  • interferes with the pathways for synthesis of pyrimidines
  • metabolized into its active form by intestinal mucosa – works by inhibiting dihydroorotate dehydrogenase thereby blocking T and B cell proliferation
  • also has limited antiviral activity
25
Q

NME prognosis

A
  • fatal without treatment
  • approx. 44-75% dogs respond to therapy; 26% die within 7 days of diagnosis
  • reported survival times; 1-1096 days
26
Q

negative prognostic indicators of NME

A
  • presence of seizures, decreased mentation, mass effect
  • higher CSF total nucleated cell count, increased neutrophil conc, abnormal CSF at 3 months post diagnosis
27
Q

What is the scientific name of rat lung worm?

A

Angiostrongylus cantonensis

28
Q

What is the life-cycle and transmission of A.cantonensis?

A

L1 passed in rat faeces –> ingested by slugs/snails and mature to L3 –> rats/other hosts ie. dogs ingest the slug –> L3 migrate from GIT to brain (develop into subadult) then migrate to pulmonary arteries –> mature and mate –> eggs hatch in lungs –> migrate to trachea and are coughed up and swallowed –> L1 pass in faeces

29
Q

CSF tests for A.cantonensis

A
  • Anti-A.cantonensis IgG in the CSF can be detected via enzyme-linked immunosorbent assay (ELISA)
  • PCR reaction
  • loop-mediated isothermal amplification (LAMP) assays
30
Q

pathophysiology of A.cantonensis meninge

A
  • L3 leave GIT via lymphatics and veins. L3 exhibit neurotropism and travel via peripheral nerves and nerve roots to CNS.
  • Damage to CNS tissue occurs from mechanical damage from larval migration and haemorrhage
  • severe eosinophilic meningoencephalitis occurs in response to larval antigens
31
Q

Treatment of A.cantonensis

A

high dose glucocorticoids for a minimum of 6-8 weeks - anthelmintics can worsen CS and result in death

32
Q
A